Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Olson

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2017
Familial Parkinson's point mutation abolishes multiple system atrophy prion replicationAmanda L Woerman, Sabeen A Kazmi, Smita Patel, et al.
Journal of Parkinson'S Disease|February 17, 2025
Structurally targeted mutagenesis identifies key residues supporting α-synuclein misfolding in multiple system atrophyPatricia M Reis, Sara Am Holec, Chimere Ezeiruaku, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 24, 2015
Pharmacokinetics and metabolism of AMG 232, a novel orally bioavailable inhibitor of the MDM2-p53 interaction, in rats, dogs and monkeys: in vitro-in vivo correlationQiuping Ye, Min Jiang, Wotang T Huang, et al.
Acta Neuropathologica|August 26, 2022
Multiple system atrophy prions transmit neurological disease to mice expressing wild-type human α-synucleinSara A M Holec, Jisoo Lee, Abby Oehler, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
Structurally targeted mutagenesis identifies key residues supporting <math></math> -synuclein misfolding in multiple system atrophyPatricia M Reis, Sara A M Holec, Chimere Ezeiruaku, et al.
JAMA Neurology|October 24, 2017
Kinetics of Human Mutant Tau Prion Formation in the Brains of 2 Transgenic Mouse LinesAmanda L Woerman, Smita Patel, Sabeen A Kazmi, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2008
4-Methyl-5-phenyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type IYuping Zhu, Steven H Olson, Anne Hermanowski-Vosatka, et al.
Organic Letters|April 30, 2021
Water-Soluble Iridium Photoredox Catalyst for the Trifluoromethylation of Biomolecule Substrates in Phosphate Buffered Saline SolventTerrence-Thang H Nguyen, Connor J O'Brien, Minh L N Tran, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2016
Tau prions from Alzheimer's disease and chronic traumatic encephalopathy patients propagate in cultured cellsAmanda L Woerman, Atsushi Aoyagi, Smita Patel, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 19, 2016
Optimization of Aryl Amides that Extend Survival in Prion-Infected MiceKurt Giles, David B Berry, Carlo Condello, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2017
Familial Parkinson's point mutation abolishes multiple system atrophy prion replicationAmanda L Woerman, Sabeen A Kazmi, Smita Patel, et al.
Journal of Parkinson'S Disease|February 17, 2025
Structurally targeted mutagenesis identifies key residues supporting α-synuclein misfolding in multiple system atrophyPatricia M Reis, Sara Am Holec, Chimere Ezeiruaku, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 24, 2015
Pharmacokinetics and metabolism of AMG 232, a novel orally bioavailable inhibitor of the MDM2-p53 interaction, in rats, dogs and monkeys: in vitro-in vivo correlationQiuping Ye, Min Jiang, Wotang T Huang, et al.
Acta Neuropathologica|August 26, 2022
Multiple system atrophy prions transmit neurological disease to mice expressing wild-type human α-synucleinSara A M Holec, Jisoo Lee, Abby Oehler, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
Structurally targeted mutagenesis identifies key residues supporting <math></math> -synuclein misfolding in multiple system atrophyPatricia M Reis, Sara A M Holec, Chimere Ezeiruaku, et al.
JAMA Neurology|October 24, 2017
Kinetics of Human Mutant Tau Prion Formation in the Brains of 2 Transgenic Mouse LinesAmanda L Woerman, Smita Patel, Sabeen A Kazmi, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2008
4-Methyl-5-phenyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type IYuping Zhu, Steven H Olson, Anne Hermanowski-Vosatka, et al.
Organic Letters|April 30, 2021
Water-Soluble Iridium Photoredox Catalyst for the Trifluoromethylation of Biomolecule Substrates in Phosphate Buffered Saline SolventTerrence-Thang H Nguyen, Connor J O'Brien, Minh L N Tran, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2016
Tau prions from Alzheimer's disease and chronic traumatic encephalopathy patients propagate in cultured cellsAmanda L Woerman, Atsushi Aoyagi, Smita Patel, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 19, 2016
Optimization of Aryl Amides that Extend Survival in Prion-Infected MiceKurt Giles, David B Berry, Carlo Condello, et al.
Pageof 5